Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent A Neuschwander-Tetri

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Current Gastroenterology Reports|February 5, 2002
Evolving pathophysiologic concepts in nonalcoholic steatohepatitisBrent A Neuschwander-Tetri
Postgraduate Medicine|December 12, 2017
Common blood tests for liver diseaseBrent A Neuschwander-Tetri
Gastroenterology|February 17, 2020
Therapeutic Landscape for NAFLD in 2020Brent A Neuschwander-Tetri
The American Journal of Clinical Nutrition|June 12, 2015
Retinoid X receptor: the forgotten partner in regulating lipid metabolism?Brent A Neuschwander-Tetri
Current Gastroenterology Reports|April 29, 2010
Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASHBrent A Neuschwander-Tetri
Nature Reviews. Gastroenterology & Hepatology|May 6, 2010
NASH: Thiazolidinediones for NASH--one pill doesn't fix everythingBrent A Neuschwander-Tetri
Current Opinion in Clinical Nutrition and Metabolic Care|May 10, 2013
Carbohydrate intake and nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri
Clinics in Liver Disease|October 13, 2009
Lifestyle modification as the primary treatment of NASHBrent A Neuschwander-Tetri
Nature Reviews. Gastroenterology & Hepatology|April 9, 2014
NASH: the tribulations of conducting NASH trialsBrent A Neuschwander-Tetri
Gastroenterology & Hepatology|March 9, 2019
Pharmacologic Management of Nonalcoholic SteatohepatitisBrent A Neuschwander-Tetri
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Current Gastroenterology Reports|February 5, 2002
Evolving pathophysiologic concepts in nonalcoholic steatohepatitisBrent A Neuschwander-Tetri
Postgraduate Medicine|December 12, 2017
Common blood tests for liver diseaseBrent A Neuschwander-Tetri
Gastroenterology|February 17, 2020
Therapeutic Landscape for NAFLD in 2020Brent A Neuschwander-Tetri
The American Journal of Clinical Nutrition|June 12, 2015
Retinoid X receptor: the forgotten partner in regulating lipid metabolism?Brent A Neuschwander-Tetri
Current Gastroenterology Reports|April 29, 2010
Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASHBrent A Neuschwander-Tetri
Nature Reviews. Gastroenterology & Hepatology|May 6, 2010
NASH: Thiazolidinediones for NASH--one pill doesn't fix everythingBrent A Neuschwander-Tetri
Current Opinion in Clinical Nutrition and Metabolic Care|May 10, 2013
Carbohydrate intake and nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri
Clinics in Liver Disease|October 13, 2009
Lifestyle modification as the primary treatment of NASHBrent A Neuschwander-Tetri
Nature Reviews. Gastroenterology & Hepatology|April 9, 2014
NASH: the tribulations of conducting NASH trialsBrent A Neuschwander-Tetri
Gastroenterology & Hepatology|March 9, 2019
Pharmacologic Management of Nonalcoholic SteatohepatitisBrent A Neuschwander-Tetri
Pageof 16